UnitedHealthcareMedicaid · Prior Auth · Medical Benefit Drug Policy · IN · Pulmonology, PharmacyMedium impact
Alpha1-Proteinase Inhibitors
Effective date
Dec 1, 2026
Identified
Nov 7, 2026
Summary
UnitedHealthcare's Community Plan Medicaid medical policy for Alpha1-Proteinase Inhibitors was updated in the November 2026 bulletin, effective 2026-12-01. The change removes language that had excluded Indiana from this Medical Benefit Drug Policy, so the policy now applies to Indiana Community Plan Medicaid members.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.
01Before 2026-12-01: Billing team should update payer-specific policy references and prior authorization checklists for Alpha1-Proteinase Inhibitor drugs so that Indiana UHC Community Plan Medicaid members are handled under this policy.
02Get prior auth before scheduling or administering Alpha1-Proteinase Inhibitor therapy for affected Indiana members, and confirm charge entry for these drugs reflects the policy's requirements.
03Tell providers and front desk staff that Indiana Community Plan Medicaid members are now subject to this policy starting 2026-12-01.
04Claims without the required prior auth will be denied.
Original notice
Alpha1-Proteinase Inhibitors
uhcprovider.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.